TYVASO for Pulmonary arterial hypertension: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 273 adverse event reports in the FDA FAERS database where TYVASO was used for Pulmonary arterial hypertension.
Most Reported Side Effects for TYVASO
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 124 | 23.7% | 123 | 7 |
| Dyspnoea | 69 | 13.2% | 2 | 55 |
| Pneumonia | 44 | 8.4% | 5 | 42 |
| Cough | 37 | 7.1% | 2 | 13 |
| Headache | 32 | 6.1% | 0 | 17 |
| Fluid retention | 26 | 5.0% | 1 | 23 |
| Chest pain | 22 | 4.2% | 0 | 15 |
| Dizziness | 22 | 4.2% | 0 | 12 |
| Pulmonary arterial hypertension | 21 | 4.0% | 7 | 14 |
| Anaemia | 15 | 2.9% | 0 | 13 |
| Oxygen saturation decreased | 15 | 2.9% | 1 | 11 |
| Condition aggravated | 13 | 2.5% | 1 | 10 |
| Diarrhoea | 13 | 2.5% | 1 | 7 |
| Fall | 13 | 2.5% | 0 | 11 |
| Fatigue | 13 | 2.5% | 1 | 3 |
Other Indications for TYVASO
Other Drugs Used for Pulmonary arterial hypertension
TREPROSTINIL (72,609)
MACITENTAN (29,246)
AMBRISENTAN (27,852)
BOSENTAN (12,387)
SELEXIPAG (11,861)
RIOCIGUAT (9,158)
EPOPROSTENOL (8,508)
TADALAFIL (7,679)
SILDENAFIL (5,239)
ILOPROST (2,828)